Three months after DarioHealth launched its smartphone-connected glucometer in the US, the company reports more than 100 percent increase in growth, bringing in $669,000 in revenue in the second quarter for 2016.

The increase is understandable, considering the US is the largest market for blood glucose markets. Israel-based Dario (which has rebranded itself, after previously operating under the name LabStyle Innovations) reported 4,900 registered users, 2,300 monthly active users and $6.4 million cash balance as of the end of June.

"During the second quarter, we materially advanced the launch of Dario in the United States, with a direct-to-consumer model and delivered significant monthly user growth, which will position us to increase sales and recurring subscription revenues beginning in the second half of 2016," Erez Raphael, CEO of DarioHealth said in a statement. 

Following the soft launch in March, device sales ramped up, particularly in June when the company sold more than 3,000 devices, representing 200 percent growth over that period. Raphael said he believes the company has the right digital marketing strategy to efficiently reach consumers, plus strong preliminary results to convert users into subscribers.

"Growing our customer base is an important step towards bringing positive changes to people with diabetes, and bringing more attention to our innovative and user centric approach which is disrupting the digital, mHealth and lifestyle market,” he said.

In July, right after the quarter’s end, DarioHealth signed an agreement with healthcare distributor GEMCO Medical to become the first authorized US distributor of Dario, complementing the company's direct-to-consumer model to further expand and strengthen its presence in the United States. Also in July, DarioHealth began offering its system direct to consumers in Australia, where it can be used on either iPhone or Android.

“Looking forward, we are working to build momentum in the US and around the world,” Raphael said. “We believe we have the right product and the right strategy to succeed in these efforts and look forward to the opportunities ahead of us. We expect sales in the second half of 2016 to accelerate as a result of increased recurring subscription revenues. The predictable nature of these subscription revenues will also provide us greater visibility into 2017 and serve as the foundation for our long-term growth."